-
TypeZero and EOFlow to Develop Closed Loop System Featuring AP Technology and Patch Insulin Pump
CHARLOTTESVILLE, Va. and SEOUL, South Korea – Digital health company TypeZero Technologies, Inc. and medical device manufacturer EOFlow Co., LTD today announced the companies have completed a license agreement to implement TypeZero’s closed loop technology alongside EOFlow’s patch insulin pump. The non-exclusive agreement allows for development of a closed loop product that can be commercialized throughout Asia. EOFlow’s EOPatch system features a disposable patch insulin pump that is among the smallest and lightes...Feb. 14. 2018 -
EOFLOW gets media coverage around the globe
With the recent joint announcement between JDRF (Juvenile Diabetes Research Fund) and EOFLOW, the company and its wearable insulin patch pump product, EOPatch, are getting some attention. Check out the links below: From MobiHealthNews: 'JDRF backs EOPatch, a tiny, wearable insulin pump' http://www.mobihealthnews.com/content/jdrf-backs-eopatch-tiny-wearable-insulin-pump From MD+DI newsletter (Qmed): 'How Two Tiny Insulin Devices Won JDRF Support' https://www.mddionline.com/how-two-tiny-insulin-devices-won-jdrf-support Fr...Feb. 06. 2018 -
EOFLOW covered in a major newspaper article
Maeil Business News Korea (www.mk.co.kr), one of the most widely read economics newspapers in Korea, runs an article on EOFLOW and its wearable automated insulin infusion system (AKA artificial pancreas) development support by JDRF (Juvenile Diabetes Research Fund). To read the Korean article, click the link below: http://news.mk.co.kr/newsRead.php?year=2018&no=63532Jan. 29. 2018 -
JDRF Partners with EOFlow to Develop Wearable Automated Insulin Delivery System for People with Type 1 Diabetes
JDRF Partners with EOFlow to Develop Wearable Automated Insulin Delivery System for People with Type 1 Diabetes —The disposable patch device would be small enough to enable use of wearable artificial pancreas technology on a child— NEW YORK, USA and SEOUL, South Korea, January 25, 2017 — JDRF, the global leading organization funding type 1 diabetes (T1D) research, is pleased to announce a new Industry Development and Discovery Partnership supporting South Korea’s EOFlow Co., Ltd. in the development of a wearable, d...Jan. 28. 2018 -
Call for shareholders' meeting (in Korean); 임시주총 소집 통지문
임시주주총회 소집 통지 주주 여러분의 번영과 안녕을 기원합니다. 당사 임시 주주총회를 다음과 같이 개최하오니 주주 여러분께서는 참석하여 주시기 바랍니다. 사정상 참석을 못하시는 주주님께서는 하기 위임장에 기명날인하여 발송해 주시기 바랍니다. -다 음- 1. 일시: 2018년 1월 23일(화요일) 오후 4시 2. 장소: 이오플로우(주) 회의실 경기도 성남시 분당구 돌마로 172 헬스케어혁신파크 H2102호 3. 회의목적사항 제 1호의 의안: 감사 임명 제 2호의 의안: 임직원 주식매수선택권 부여 승인 별첨: 1. 위임장 2018년 01월 08일 이오플로우 주식회사 공동대표이사 김 재 진 (직인생략) 공동...Jan. 08. 2018 -
EOFLOW chosen as the best TIPS company of 2017
EOFLOW was voted the best TIPS-backed company of 2017 at the '2017 TIPS Grand Convention.' The selection was based on weighed scores of votes from a group of investors as well as the convention attendees. TIPS (Tech Incubator Program for Start-up) is a startup incubation program sponsored by Ministry of SME and Startups (MSS), and jointly run by Korea Business Angels Association, private angels & incubator groups. TIPS has been widely considered the best-run incubation program in Korea that it is bei...Dec. 21. 2017 -
EOPatch gets its first regulatory approval
EOPatch, the first wearable disposable insulin pump product from EOFLOW, got its first regulatory approval, from the Korean MFDS (Ministry of Food and Drug Safety). EOFLOW will immediately start preceding clinical trials and plans to launch the product in Korea this coming spring. Earlier, EOFLOW has appointed Huons (www.huons.com) as the exclusive distributor of EOPatch in the Korean market.Dec. 18. 2017 -
EOPatch awarded GD (Good Design) designation
EOFLOW's wearable disposable insulin pump product, EOPatch, was recently awarded the highly selective Good Design (GD) designation. Hosted annually by Korea Institute of Design Promotion (KIDP) and sponsored by the Korean Ministry of Trade, Industry & Energy (MOTIE), the GD Selection is subject to highly competitive selection processes, and the designation is yet another validation of the excellence of the design and usability of EOPatch. The picture below is EOPatch on display during the Sele...Dec. 13. 2017 -
Luis Malave joins as new president of EOFLOW
Mr. Luis Malave, a long-time industry insider who has contributed significantly to the emergence of the smart insulin patch pump industry, has joined EOFLOW as the new president. Luis was one of the earliest employees at Insulet and was the COO of the company at the time he left. He was also an early member of MiniMed. Prior to this, he also worked at Medtronic and University of Minnesota.Oct. 17. 2017 -
Dr. David Klonoff joins as a Scientific Advisory Board member
EOFLOW announces that David Klonoff, M.D. has joined EOFLOW as the latest member of its Scientific Advisory Board. Dr. Klonoff is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF. He has been a Principal Investigator on 110 clinical trials of diabetes drugs and devices, and has been lead investigator on multicenter trials for Novo, Sanofi, Diasome, and Medtronic. He was the lead investigator for th...Oct. 16. 2017
Healthcare Innovation Park #H2102 Dolma-ro 172 Bundang-gu Seongnam-si Gyeonggi-do Republic of Korea
T (+82) 031-738-0200
F (+82) 031-738-0208
COPYRIGHT ⓒ 2017 EOFLOW CO., LTD. All Rights Reserved.
